跳至主要内容
临床试验/ACTRN12621001033831
ACTRN12621001033831招募中未知

Indocyanine green compared with technetium-99m for sentinel lymph node biopsy in early breast cancer: The FLUORO trial

Chris O'Brien Lifehouse0 个研究点目标入组 290 人开始时间: 2021年8月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
290

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Participant has clinically node-negative early breast cancer undergoing sentinel lymph node biopsy
  • - Female, age 18 years or older
  • - Participant understands the study procedures and can provide informed consent to participate in the study

排除标准

  • - Participant does not have clinically node-negative early breast cancer (tumour size >3 cm +/- clinically positive lymph nodes)
  • - Participant has known contraindication to ICG injection, i.e., previous reaction to ICG
  • - Participant has Iodine allergy
  • - Participant has chronic kidney disease stage 3, 4, or 5
  • - Participant is pregnant
  • - Refusal to consent to participation in the study

研究者

相似试验